Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, August 23, 2017
Trial By Fire Solutions has released SimpleTrials 2.0, a clinical trial management system (CTMS) with new features such as site contracts and payments management.
read more
Spray drying and capsule filling service provider Micro-Sphere is investing €19 million into expanding its GMP manufacturing capabilities at its facility in Switzerland.
read more
Cmed has announced it will present its encapsia clinical data suite at Mobile in Clinical Trials and DPharm: Disruptive Innovations to Advance Clinical Trials 2017.
read more
Crown Bioscience announced the appointment of Dr. Leon Hall as Vice President of Global Scientific Excellence.
read more
Dr. Reddy’s Laboratories has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology.
read more
Oxford Genetics announced a £7.5 million investment into its operations in the US and the UK by Mercia Technologies PLC, an existing investor, and Invesco Perpetual.
read more
Medidata announced an enterprise agreement with Chinese healthcare group, Shanghai Fosun Pharmaceutical.
read more
Champions Oncology announced a strategic collaboration with AstraZeneca to develop novel cohorts of PDX models.
read more
Avista Healthcare and Envigo, an early stage non-clinical contract research organization jointly announced that they have entered into a definitive merger agreement.
read more
Evotec AG announced has successfully completed the acquisition of Aptuit as announced in detail on 30 July 2017.
read more
PAREXEL and Osaka International Cancer Institute announced that they have formed an alliance to advance clinical development in Japan.
read more
Ligand Pharmaceuticals announced the appointment of Nancy Ryan Gray, Ph.D. to the company’s Board of Directors.
read more
Allscripts has partnered with Elligo Health Research to assist clinicians to conduct clinical trial studies in their own clinics.
read more
Ligand will receive a $2 million payment from WuXi Biologics subsequent to their licensing of exclusive rights to the anti-PD-1 antibody GLS-010 to Arcus Biosciences.
read more
QPharma, a premier provider of compliance and commercial services to the life sciences industry, is expanding its footprint with the opening of a new office in the Somerset area of New Jersey.
read more